A role for the Ca2+-dependent tyrosine kinase Pyk2 in tonic depolarization-induced vascular smooth muscle contraction

Journal of Muscle Research and Cell Motility

Volumn 36, Issue 6, 2015, Pages 479-489

  Mills, Ryan D ^a   Mita, Mitsuo ^b   Walsh, Michael P ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Calcium sensitization; Contractile regulation; Membrane depolarization; Pyk2; Tyrosine phosphorylation; Vascular smooth muscle

Indexed keywords

CALCIUM; FOCAL ADHESION KINASE 2; MYOSIN LIGHT CHAIN; RHO KINASE;

ANIMAL; MEMBRANE POTENTIAL; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCIUM; FOCAL ADHESION KINASE 2; MEMBRANE POTENTIALS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOSIN LIGHT CHAINS; RHO-ASSOCIATED KINASES;

EID: 84936806526     PISSN: 01424319     EISSN: 15732657     Source Type: Journal    
DOI: 10.1007/s10974-015-9416-2     Document Type: Review

References (78)

1. Adegunloye BJ, Su X, Camper EV, Moreland RS (2003) Sensitivity of rabbit aorta and mesenteric artery to norepinephrine: role of tyrosine kinases. Eur J Pharmacol 476:201–209
2. Arcaro A, Zvelebil MJ, Wallasch C, Ullrich A, Waterfield MD, Domin J (2000) Class II phosphoinositde 3-kinases are downstream targets of activated polypeptide growth factor receptors. Mol Cell Biol 20:3817–3830
3. Avraham H, Park SY, Schinkmann K, Avraham S (2000) RAFTK/Pyk2-mediated cellular signalling. Cell Signal 12:123–133
4. Baumann BAJ, Taylor DW, Huang Z, Tama F, Fagnant PM, Trybus KM, Taylor KA (2012) Phosphorylated smooth muscle heavy meromyosin shows an open conformation linked to activation. J Mol Biol 415:274–287
5. Bolton TB (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59:606–718
6. 2+ sensitization as a component of electromechanical and pharmacomechanical coupling in rat ureteric smooth muscle. Cell Calcium 50:393–405
7. Chen CP, Chen X, Qiao YN, Wang P, He WQ, Zhang CH, Zhao W, Gao YQ, Chen C, Tao T, Sun J, Wang Y, Gao N, Kamm KE, Stull JT, Zhu MS (2015) In vivo roles for myosin phosphatase targeting subunit-1 phosphorylation sites T694 and T852 in bladder smooth muscle contraction. J Physiol 593:681–700
8. Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, Pfitzer G (1993a) Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun 190:968–974
9. Di Salvo J, Semenchuk LA, Lauer J (1993b) Vanadate-induced contraction of smooth muscle and enhanced protein tyrosine phosphorylation. Arch Biochem Biophys 304:386–391
10. 2+ sensitivity for contraction of smooth muscle. Can J Physiol Pharmacol 72:1434–1439
11. Feng J, Ito M, Kureishi Y, Ichikawa K, Amano M, Isaka N, Okawa K, Iwamatsu A, Kaibuchi K, Hartshorne DJ, Nakano T (1999a) Rho-associated kinase of chicken gizzard smooth muscle. J Biol Chem 274:3744–3752
12. Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, Nakano T (1999b) Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 274:37385–37390
13. 2+ sensitization of smooth muscle. J Biol Chem 272:10704–10709
14. Gunst SJ, Zhang W (2008) Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction. Am J Physiol Cell Physiol 295:C576–C587
15. Han S, Mistry A, Chang JS, Cunningham D, Griffor M, Bonnette PC, Wang H, Chrunyk BA, Aspnes GE, Walker DP, Brosius AD, Buckbinder L (2009) Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design. J Biol Chem 284:13193–13201
16. Hollenberg MD (1994) Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 15:108–114
17. Hong F, Haldeman BD, Jackson D, Carter M, Baker JE, Cremo CR (2011) Biochemistry of smooth muscle myosin light chain kinase. Arch Biochem Biophys 510:135–146
18. Ichikawa K, Ito M, Hartshorne DJ (1996) Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity. J Biol Chem 271:4733–4740
19. Kanda T, Wakino S, Homma K, Yoshioka K, Tatematsu S, Hasegawa K, Takamatsu I, Sugano N, Hayashi K, Saruta T (2006) Rho kinase as a molecular target for insulin resistance and hypertension. FASEB J 20:169–171
20. Khasnis M, Nakatomi A, Gumpper K, Eto M (2014) Reconstituted human myosin light chain phosphatase reveals distinct roles of two inhibitory phosphorylation sites of the regulatory subunit, MYPT1. Biochemistry 53:2701–2709
21. 2+ sensitization in rat arterial smooth muscle. J Physiol 590:5401–5423
22. Kitazawa T, Eto M, Woodsome TP, Brautigan DL (2000) Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275:9897–9900
23. 2+ sensitization in rabbit smooth muscle. J Physiol 546:879–889
24. 2+/calmodulin to FERM F2 α2 helix and thus forming its dimer. Biochem J 410:513–523
25. Koyama M, Ito M, Feng J, Seko T, Shiraki K, Takase K, Hartshorne DJ, Nakano T (2000) Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett 475:197–200
26. Laniyonu AA, Saifeddine M, Yang SG, Hollenberg MD (1994) Tyrosine kinase inhibitors and the contractile action of G-protein-linked vascular agonists. Can J Physiol Pharmacol 72:1075–1085
27. Leung T, Manser E, Tan L, Lim L (1995) A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes. J Biol Chem 270:29051–29054
28. Lipinski CA, Loftus JC (2010) The Pyk2 FERM domain: a novel therapeutic target. Expert Opin Ther Targets 14:95–108
29. Lu PJ, Chen CS (1997) Selective recognition of phosphatidylinositol 3,4,5-trisphosphate by a synthetic peptide. J Biol Chem 272:466–472
30. Mabuchi Y, Mabuchi K, Stafford WF, Grabarek Z (2010) Modular structure of smooth muscle myosin light chain kinase: hydrodynamic modeling and functional implications. Biochemistry 49:2903–2917
31. 2+ sensitivity of vascular smooth muscle contraction. Life Sci 68:363–372
32. Mills RD, Mita M, Nakagawa J, Shoji M, Sutherland C, Walsh MP (2015) A role for the tyrosine kinase Pyk2 in depolarization-induced contraction of vascular smooth muscle. J Biol Chem 290:8677–8692
33. Missy K, Van Poucke V, Raynal P, Viala C, Mauco G, Plantavid G, Chap H, Payrastre B (1998) Lipid products of phosphoinositide 3-kinase interact with Rac1 GTPase and stimulate GDP dissociation. J Biol Chem 273:30279–30286
34. 1-Adrenoceptor-mediated phosphorylation of myosin in rat-tail arterial smooth muscle. Biochem J 327:669–674
35. Mita M, Yanagihara H, Hishinuma S, Saito M, Walsh MP (2002) Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase. Biochem J 364:431–440
36. Mita M, Tanaka H, Yanagihara H, Nakagawa J, Hishinuma S, Sutherland C, Walsh MP, Shoji M (2013) Membrane depolarization-induced RhoA/Rho-associated kinase activation and sustained contraction of rat caudal arterial smooth muscle involves genistein-sensitive tyrosine phosphorylation. J Smooth Muscle Res 49:26–45
37. Mori M, Tsushima H (2004) Vanadate activates RhoA translocation in association with contracting effects in ileal longitudinal smooth muscle of guinea pig. J Pharmacol Sci 95:443–451
38. Murányi A, Derkach D, Erdődi F, Kiss A, Ito M, Hartshorne DJ (2005) Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells. FEBS Lett 579:6611–6615
39. 2+ sensitization of coronary artery contraction mediated by a sphingosylphosphorylcholine-Rho-kinase pathway. Circ Res 91:953–960
40. Ohanian V, Gatfield K, Ohanian J (2005) Role of the actin cytoskeleton in G-protein-coupled receptor activation of PYK2 and paxillin in vascular smooth muscle. Hypertension 46:93–99
41. Paulhe F, Perret B, Chap H, Iberg N, Morand O, Racaud-Sultan C (2002) Phosphoinositide 3-kinase C2α is activated upon smooth muscle cell migration and regulated by α v β 3 integrin engagement. Biochem Biophys Res Commun 297:261–266
42. Ratz PH (1990) Effect of the kinase inhibitor, H-7, on stress, crossbridge phosphorylation, muscle shortening and inositol phosphate production in rabbit arteries. J Pharmacol Exp Ther 252:253–259
43. Ratz PH, Berg KM, Urban NH, Miner AS (2005) Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus. Am J Physiol Cell Physiol 288:C769–C783
44. 2 participates in KCl-induced calcium sensitization of vascular smooth muscle. Cell Calcium 46:65–72
45. Rocic P, Griffin TM, McRae CN, Lucchesi PA (2002) Altered Pyk2 phosphorylation by ANG II in hypertensive vascular smooth muscle. Am J Physiol Heart Circ Physiol 282:H457–H465
46. Sabri A, Govindarajan G, Griffin TM, Byron KL, Samarel AM, Lucchesi PA (1998) Calcium and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle. Circ Res 83:841–851
47. +-induced contraction by the ROCKs inhibitor Y-27632 in vascular smooth muscle: possible involvement of ROCKs in a signal transduction pathway. J Pharmacol Sci 92:56–69
48. Sakurada S, Okamoto H, Takuwa N, Sugimoto N, Takuwa Y (2001) Rho activation in excitatory agonist-stimulated vascular smooth muscle. Am J Physiol Cell Physiol 281:C571–C578
49. 2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ Res 93:548–556
50. Sasaki H, Kazuko N, Ishino M, Tobioka H, Kotani K, Sasaki T (1995) Cloning and characterization of cell adhesion kinase β, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J Biol Chem 270:21206–21219
51. 2+ sensitization of smooth muscle of rabbit mesenteric artery. Br J Pharmacol 125:1651–1660
52. Seok YM, Baek I, Kim YH, Jeong YS, Lee IJ, Shin DH, Hwang YH, Kim IK (2008) Isoflavone attenuates vascular contraction through inhibition of the RhoA/Rho-kinase signaling pathway. J Pharmacol Exp Ther 326:991–998
53. Shimada T, Shimamura K, Sunano S (1986) Effects of sodium vanadate on various types of vascular smooth muscles. Blood Vessels 23:113–124
54. Somlyo AP, Somlyo AV (2000) Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522:177–185
55. 2+ sensitivity in smooth muscle by genistein and protein tyrosine phosphorylation. Arch Biochem Biophys 320:236–242
56. Stull JT, Lin PJ, Krueger JK, Trewhella J, Zhi G (1998) Myosin light chain kinase: functional domains and structural motifs. Acta Physiol Scand 164:471–482
57. Sutherland C, Walsh MP (2012) Myosin regulatory light chain diphosphorylation slows relaxation of arterial smooth muscle. J Biol Chem 287:24064–24076
58. Takeya K, Loutzenhiser K, Shiraishi M, Loutzenhiser RD, Walsh MP (2008) A highly sensitive technique to measure myosin regulatory light chain phosphorylation: the first quantification in renal arterioles. Am J Physiol Renal Physiol 294:F1487–F1492
59. 2+ level and contraction in vascular smooth muscle. Eur J Pharmacol 250:431–437
60. Taylor KA, Feig M, Brooks CL III, Fagnant PM, Lowey S, Trybus KM (2014) Role of the essential light chain in the activation of smooth muscle myosin by regulatory light chain phosphorylation. J Struct Biol 185:375–382
61. Turner SJ, Domin J, Waterfield MD, Ward SG, Westwick J (1998) The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2α. J Biol Chem 273:25987–25995
62. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990–994
63. 2+ sensitization of arterial muscle. Am J Physiol Cell Physiol 285:C1377–C1385
64. Velasco G, Armstrong C, Morrice N, Frame S, Cohen P (2002) Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1 M at Thr850 induces its dissociation from myosin. FEBS Lett 527:101–104
65. Walsh MP, Cole WC (2013) The role of actin filament dynamics in the myogenic response of cerebral resistance arteries. J Cereb Blood Flow Metab 33:1–12
66. Wang Z, Brecher P (2001) Salicylate inhibits phosphorylation of the nonreceptor tyrosine kinases, proline-rich tyrosine kinase-2 and c-Src. Hypertension 37:148–153
67. Wang Y, Yoshioka K, Azam MA, Takuwa N, Sakurada S, Kayaba Y, Sugimoto N, Inoki I, Kimura T, Kuwaki T, Takuwa Y (2006) Class II phosphoinositide 3-kinase α-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. Biochem J 394:581–592
68. 2+-independent phosphorylation of myosin in rat caudal artery and chicken gizzard myofilaments. J Physiol 516:805–824
69. Wendt T, Taylor D, Trybus KM, Taylor K (2001) Three-dimensional image reconstruction of dephosphorylated smooth muscle heavy meromyosin reveals asymmetry in the interaction between myosin heads and placement of subfragment 2. Proc Natl Acad Sci USA 98:4361–4366
70. Williams DA, Fay FS (1986) Calcium transients and resting levels in isolated smooth muscle cells as monitored with quin 2. Am J Physiol Cell Physiol 250:C779–C791
71. Williams DA, Becker PL, Fay FS (1987) Regional changes in calcium underlying contraction of single smooth muscle cells. Science 235:1644–1648
72. 2+. J Biol Chem 277:2186–2192
73. Wu X, Clack BA, Zhi G, Stull JT, Cremo CR (1999) Phosphorylation-dependent structural changes in the regulatory light chain domain of smooth muscle heavy meromyosin. J Biol Chem 274:20328–20335
74. 2+ sensitivity of contractile elements in coronary arterial smooth muscle. Am J Physiol Heart Circ Physiol 267:H614–H621
75. Ying Z, Giachini FRC, Tostes RC, Webb RC (2009a) Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation. Cardiovasc Res 83:155–162
76. 2+ signaling to RhoA. Arterioscler Thromb Vasc Biol 29:1657–1663
77. 2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells. Mol Pharmacol 71:912–920
78. Yu H, Li X, Marchetto GS, Dy R, Hunter D, Calvo B, Dawson TL, Wilm M, Anderegg RJ, Graves LM, Earp HS (1996) Activation of a novel calcium-dependent protein-tyrosine kinase. J Biol Chem 271:29993–29998